Skip to main content

How to Calculate Ozempic Face Risk

What is Ozempic Face Risk?

The Ozempic Face Volume Loss Estimator predicts the degree of facial volume loss associated with rapid weight loss from GLP-1 medications. Colloquially known as "Ozempic face," this calculator estimates facial fat pad reduction based on total weight loss, age, and starting facial fat distribution.

Formula

Facial Volume Loss Index = Total %BWL × Age Factor × Facial Fat Susceptibility Score
%BWL
Body Weight Loss (%) — Total percentage of body weight lost
A
Age (years) — Patient age (volume loss more noticeable over 40)
FFS
Facial Fat Susceptibility (1-5 scale) — Baseline facial fullness and susceptibility to volume depletion
FVLI
Facial Volume Loss Index (1-10 scale) — Predicted severity of noticeable facial volume depletion

Step-by-Step Guide

  1. 1Enter your age, total weight lost, and rate of weight loss
  2. 2Estimate your facial fat distribution (fuller face vs. naturally lean face)
  3. 3The calculator estimates your risk of noticeable facial volume loss on a 1-10 scale
  4. 4View recommendations for mitigation including filler options and their estimated costs

Worked Examples

Input
Age 55, lost 45 lbs (20% BWL) on semaglutide over 10 months, naturally full face
Result
Facial Volume Loss Index: 7.2/10 (HIGH). At 20% BWL over age 50, significant facial fat pad deflation expected. Nasolabial folds, under-eye hollowing, and temporal wasting likely. Filler estimate: 4-6 syringes ($2,800-$5,400).
Input
Age 35, lost 25 lbs (12% BWL) on tirzepatide over 8 months
Result
Facial Volume Loss Index: 3.1/10 (LOW-MODERATE). Younger skin elasticity and moderate weight loss reduce impact. Minor nasolabial deepening possible. Filler likely not needed.

Common Mistakes to Avoid

  • Attributing all facial changes to the medication when natural aging also contributes to volume loss over the treatment period
  • Seeking dermal filler before weight has stabilized — filling during active weight loss often requires costly revision
  • Not considering that facial volume loss may partially reverse if weight regain occurs after medication discontinuation

Frequently Asked Questions

What is Ozempic face and how common is it?

"Ozempic face" describes facial volume loss, sagging, and hollowing caused by rapid fat loss from GLP-1 medications. It is most noticeable in patients over 40 who lose 15%+ of body weight. The face has concentrated fat pads that deflate with weight loss, and skin elasticity decreases with age, making these changes more visible than on the body.

Can Ozempic face be reversed?

Yes, partially. Dermal fillers (hyaluronic acid like Juvederm or Restylane) can restore volume to the midface, temples, and nasolabial folds. Biostimulators like Sculptra promote collagen production for more gradual restoration. Costs range from $2,000-$6,000+ depending on the degree of correction needed. Results are temporary and require maintenance.

Ready to calculate? Try the free Ozempic Face Risk Calculator

Try it yourself →

Settings

PrivacyTermsAbout© 2026 PrimeCalcPro